XORTX Therapeutics Statistics
Total Valuation
XRTX has a market cap or net worth of $3.38 million. The enterprise value is $2.43 million.
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XRTX has 5.21 million shares outstanding. The number of shares has increased by 46.89% in one year.
| Current Share Class | 5.21M |
| Shares Outstanding | 5.21M |
| Shares Change (YoY) | +46.89% |
| Shares Change (QoQ) | +1.37% |
| Owned by Insiders (%) | 2.62% |
| Owned by Institutions (%) | 4.66% |
| Float | 5.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.67 |
| P/TBV Ratio | 1.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.78 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -79.44% and return on invested capital (ROIC) is -64.89%.
| Return on Equity (ROE) | -79.44% |
| Return on Assets (ROA) | -42.15% |
| Return on Invested Capital (ROIC) | -64.89% |
| Return on Capital Employed (ROCE) | -125.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$626,950 |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.22% in the last 52 weeks. The beta is -0.18, so XRTX's price volatility has been lower than the market average.
| Beta (5Y) | -0.18 |
| 52-Week Price Change | -58.22% |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 0.91 |
| Relative Strength Index (RSI) | 39.71 |
| Average Volume (20 Days) | 5,997,021 |
Short Selling Information
The latest short interest is 7,330, so 0.14% of the outstanding shares have been sold short.
| Short Interest | 7,330 |
| Short Previous Month | 31,155 |
| Short % of Shares Out | 0.14% |
| Short % of Float | 0.14% |
| Short Ratio (days to cover) | 0.14 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.54M |
| Pretax Income | -1.88M |
| Net Income | -1.88M |
| EBITDA | -2.55M |
| EBIT | -2.54M |
| Earnings Per Share (EPS) | -$0.55 |
Full Income StatementBalance Sheet
The company has $1.06 million in cash and $80,473 in debt, giving a net cash position of $983,004 or $0.19 per share.
| Cash & Cash Equivalents | 1.06M |
| Total Debt | 80,473 |
| Net Cash | 983,004 |
| Net Cash Per Share | $0.19 |
| Equity (Book Value) | 2.03M |
| Book Value Per Share | 0.54 |
| Working Capital | 553,065 |
Full Balance SheetCash Flow
| Operating Cash Flow | -3.08M |
| Capital Expenditures | n/a |
| Free Cash Flow | -3.08M |
| FCF Per Share | -$0.59 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
